Tufts University Boston

This seminar and panel discussion will focus on best practices for surviving peer review and successfully resubmitting an NIH proposal. Seasoned PIs will review reasoning and rationale behind changes they have made in response to study section review. Drawing on insights they have gained as applicants, reviewers, and mentors, they will delve into approaches to evaluating Summary Statements

Clinical trial feasibility – it’s a standard part of recruitment planning and essential for predicting enrollment success. Yet so often it’s easy to get wrong, putting timelines and budget at risk. And whether that’s because there’s too great a focus on quantitative factors – such as volume of patients or number of competing studies – it’s clear that study sponsors and sites can benefit from an

What is stakeholder and community engagement (SCE), and why is it important? Learn the benefits, strategies, and methods at Stakeholder Engagement in Patient-Centered Comparative Effectiveness Research. This seminar, taught by Thomas Concannon, PhD, Tufts CTSI’s Director of Stakeholder and Community Engagement and Assistant Director of Comparative Effectiveness Research, will review previous

When you spend most of your research in a lab, the idea of engaging stakeholders in research may not seem tangible or practical. In this course, Thomas Concannon, PhD, Co-Director of Tufts CTSI Stakeholder and Community Engagement, interviews Jonathan Garlick, DDS, PhD, Tufts University School of Dental Medicine, whose journey of stakeholder engagement has transformed his stem cell research. Learn

Sexual and gender minority (SGM) is an umbrella term that encompasses lesbian, gay, bisexual, and transgender populations as well as those whose sexual orientation, gender identity and expressions, or reproductive development varies from traditional, societal, cultural, or physiologic norms. Research with SGM populations is lacking, but is desperately needed to help understand and improve their

Why is it important to include older adults in research, and how can it improve your study? NIH’s new policy on Inclusion Across the Lifespan went into effect January 2019 requiring the inclusion of people of all ages in research studies. In this course, you will find out the scientific and ethical reasoning behind this policy change, especially as it pertains to the inclusion of older adults in

Learn how to make your research patient-centered, and find out how engagement fits into your research process at Preparing for Patient-Centered and Stakeholder-Engaged Research. Thomas Concannon, PhD, Tufts CTSI’s Co-Director of Stakeholder and Community Engagement, will share his expertise and explain several models for engaging with stakeholders.

This lecture provides researchers with practical guidance for carrying out and evaluating multi-stakeholder engaged research projects. The material presented can assist researchers to consider more systematically which stakeholder groups to involve, in what study roles, and by what modes of engagement. By documenting how stakeholders are paired up with specific roles, the matrix also provides a

Need a larger sample size for your clinical trial? Interested in increasing research participation from children with diverse backgrounds? Want to prepare to conduct regulatory science in an ever-changing networked environment? The content in this course was presented on April 18, 2018 in Washington, D.C., as part of the Association for Clinical and Translational Science (ACTS) 2018 meeting.

The content in this course was presented on April 18, 2018 in Washington, D.C., as part of the Association for Clinical and Translational Science (ACTS) 2018 meeting.

This talk was presented as part of The Odyssey of OHDSI: Using Health Care Data for Research. You will be introduced to using one of the most mature OHDSI analytic tool sets in developing patient-level prediction models.

This talk was presented as part of The Odyssey of OHDSI: Using Health Care Data for Research. You will learn how data are represented by vocabularies in the OMOP CDM and how to use the ATLAS toolset to define cohorts. Presented by Christian Reich, MD, PhD, Real World Analytics Solutions, IQVIA

This short course provides an overview of two common implementation frameworks used in grant proposals, RE-AIM (the Reach, Effectiveness, Adoption, Implementation, and Maintenance Framework) and CFIR (the Consolidated Framework for Implementation Research), and how the CFIR framework, combined with ERIC (Expert Recommendations for Implementing Change) strategies, can be used in planning for

What are successful strategies for recruiting and retaining patient participants in research? We know you know. Study after study shows that recruiting and retaining study participants is one of the weakest links in clinical research. Energize yourself with this interactive course to learn how to adopt a patient-centric mindset for clinical research. Understanding the principles and standards that

Interested in learning about novel data analysis methods and tools for addiction research? To better understand the science of addiction disorders, the research community needs continuous development of novel methods across the translational research spectrum, from personalized medicine to epidemiology.

The goal of medicine and research should be that “all patients, of all backgrounds, get the care they need when they interface with our health care system” (Joyce Sackey, MD, Tufts University Associate Provost and Chief Diversity Officer). Are we doing enough to reach this goal?

What is a pragmatic trial, and what methodological challenges should you consider?

This course presents expert discussion held in 2016 on NIH Rigor and Transparency Guidelines, led by John Castellot, PhD, Tufts CTSI Navigator and NIH Study Section Chair, and Amy Gantt, MA, Tufts University Director of Research Development. Faculty members who had participated in NIH study sections will provide valuable feedback and advice on how to include scientific rigor and transparency in